Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information

v3.2.0.727
10. Segment and Geographic Information
 3 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
10. Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

 

    Three Months Ended June 30,  
Product related revenues   2015     2014  
  United States   $ 787,000     $ 355,000  
  Latin America     1,558,000       1,093,000  
  Europe and Rest of the World     571,000       673,000  
      2,916,000       2,121,000  
  Product license fees and royalties     447,000       1,049,000  
  Total product related revenues   $ 3,363,000     $ 3,170,000  

 

The following table shows the Company’s product license fees and royalties revenues by partner:

 

    Three Months Ended June 30,  
Product license fees and royalties   2015     2014  
  Exeltis (formerly Quinnova)   $ 54,000     $ 146,000  
  Innovacyn     20,000       528,000  
  Laboratorios Sanfer (formerly More Pharma)     373,000       375,000  
Total product license fees and royalties   $ 447,000     $ 1,049,000  

 

The Company’s service revenues amounted to $317,000 and $222,000 for the three months ended June 30, 2015 and 2014, respectively.